sg301
mAbexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jan 15, 2021 (NCT04684108)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07087314 | Phase 2 | Aug 25, 2025 | Zhejiang University |
| NCT06508983 | Phase 3 | Jun 14, 2024 | Hangzhou Sumgen Biotech Co., Ltd. |
| NCT06144710 | Phase 1 | Nov 10, 2023 | Hangzhou Sumgen Biotech Co., Ltd. |
| NCT04684108 | Phase 1 | Jan 15, 2021 | Hangzhou Sumgen Biotech Co., Ltd. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hangzhou Sumgen Biotech Co., Ltd. | For profit | 3 | 3 | 2 | 2021 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1